Oruka Therapeutics, Inc. - Common Stock (NQ:ORKA)
111.04
+2.92
(+2.70%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 14, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 1,047,429 |
| Open | 106.02 |
| Bid (Size) | 108.00 (100) |
| Ask (Size) | 119.99 (100) |
| Prev. Close | 108.12 |
| Today's Range | 105.10 - 111.37 |
| 52wk Range | 14.08 - 111.37 |
| Shares Outstanding | 14,410,143 |
| Dividend Yield | 17.43% |
Top News
More News
Performance
More News
Read More
These stocks are gapping in today's session ↗
April 27, 2026
Top movers in Monday's pre-market session ↗
April 27, 2026
VR Adviser Adds Over 1 Million Savara Shares ↗
March 15, 2026
Oruka Therapeutics to Participate in Multiple Upcoming Conferences
February 09, 2026
Frequently Asked Questions
Is Oruka Therapeutics, Inc. - Common Stock publicly traded?
Yes, Oruka Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Oruka Therapeutics, Inc. - Common Stock trade on?
Oruka Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Oruka Therapeutics, Inc. - Common Stock?
The ticker symbol for Oruka Therapeutics, Inc. - Common Stock is ORKA on the Nasdaq Stock Market
What is the current price of Oruka Therapeutics, Inc. - Common Stock?
The current price of Oruka Therapeutics, Inc. - Common Stock is 111.04
When was Oruka Therapeutics, Inc. - Common Stock last traded?
The last trade of Oruka Therapeutics, Inc. - Common Stock was at 08/14/26 04:00 PM ET
What is the market capitalization of Oruka Therapeutics, Inc. - Common Stock?
The market capitalization of Oruka Therapeutics, Inc. - Common Stock is 1.60B
How many shares of Oruka Therapeutics, Inc. - Common Stock are outstanding?
Oruka Therapeutics, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube